APP, Human (Donanemab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-APP, Human (Donanemab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityAPP, Human (Donanemab biosimilar)
CloneDonanemab
Host SpeciesRecombinant
Reactive Specieshuman
IsotypeIgG1 kappa
Formatpurified
Size1mg, 5mg
Concentration1mg/ml
Applicationsn/a
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Human APP Recombinant Antibody (Donanemab). Donanemab (USAN, development code LY3002813) is a biological drug in trial to treat early symptoms of Alzheimer's disease. There is no cure or treatment for Alzheimer's disease. Donanemab has shown positive results in Eli Lilly and Co.'s first two trials.
Immunogenn/a
Other NamesAnti-APP Recombinant Antibody, Research Grade Donanemab, Anti-Human APP Recombinant Antibody(Donanemab), LY3002813, Antibody Drug Analogues, Monoclonal Antibody, YR1541, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 1931944-80-7
Catalog #YR1541
Priceplease inquire
Order / More InfoAPP, Human (Donanemab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.